A Predictive Model for Severe COVID-19 in the Medicare Population: A Tool for Prioritizing Primary and Booster COVID-19 Vaccination

被引:9
作者
Experton, Bettina [1 ]
Tetteh, Hassan A. [2 ]
Lurie, Nicole [3 ,4 ]
Walker, Peter [5 ]
Elena, Adrien [1 ]
Hein, Christopher S. [1 ]
Schwendiman, Blake [1 ]
Vincent, Justin L. [6 ]
Burrow, Christopher R. [1 ]
机构
[1] Humetrix Inc, Del Mar, CA 90214 USA
[2] Dept Def Joint Artificial Intelligence Ctr JAIC, Warfighter Hlth Mission Team, Arlington, VA 22202 USA
[3] Coalit Epidem Preparedness Innovat CEPI, Washington, DC 20006 USA
[4] Harvard Med Sch, Dept Med, Boston, MA 02115 USA
[5] US Navy, Washington, DC 20376 USA
[6] Amazon Web Serv Inc, Seattle, WA 98109 USA
来源
BIOLOGY-BASEL | 2021年 / 10卷 / 11期
关键词
COVID-19 vaccine prioritization; COVID-19 booster vaccine; severe COVID-19 disease; risk for severe COVID-19 infection; COVID-19 vaccine booster prioritization; Medicare population; severe COVID-19 risk model;
D O I
10.3390/biology10111185
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple SummaryWhether it is for COVID-19 primary vaccination or the administration of booster vaccines, prioritization criteria need to be established to optimize COVID-19 vaccination programs accounting for both clinical and social vulnerability risks for severe COVID-19 disease. We developed a dual socio-clinical risk model for severe COVID-19 disease in the Medicare population, which is comprised mostly of individuals aged 65 and over. Our model generated risk levels correlated with regionalized COVID-19 case hospitalization rates and mapped them at the county and zip code levels. The model and map can be used by health jurisdictions to reach out to unvaccinated individuals. Our model approach can also be applied to identify Medicare beneficiaries who were in early vaccination groups to be vaccinated to identify those who might maximally benefit from an additional dose of COVID-19 vaccine if and when vaccine immunity wanes.Recommendations for prioritizing COVID-19 vaccination have focused on the elderly at higher risk for severe disease. Existing models for identifying higher-risk individuals lack the needed integration of socio-demographic and clinical risk factors. Using multivariate logistic regression and random forest modeling, we developed a predictive model of severe COVID-19 using clinical data from Medicare claims for 16 million Medicare beneficiaries and socio-economic data from the CDC Social Vulnerability Index. Predicted individual probabilities of COVID-19 hospitalization were then calculated for population risk stratification and vaccine prioritization and mapping. The leading COVID-19 hospitalization risk factors were non-white ethnicity, end-stage renal disease, advanced age, prior hospitalization, leukemia, morbid obesity, chronic kidney disease, lung cancer, chronic liver disease, pulmonary fibrosis or pulmonary hypertension, and chemotherapy. However, previously reported risk factors such as chronic obstructive pulmonary disease and diabetes conferred modest hospitalization risk. Among all social vulnerability factors, residence in a low-income zip code was the only risk factor independently predicting hospitalization. This multifactor risk model and its population risk dashboard can be used to optimize COVID-19 vaccine allocation in the higher-risk Medicare population.
引用
收藏
页数:17
相关论文
共 39 条
  • [11] Centers for Disease Control and Prevention, 2021, CDC SVI 2018 DOC
  • [12] Centers for Disease Control and Prevention, U.S. Influenza surveillance: purpose and methods
  • [13] Centers for Medicare and Medicaid Services, 2018, CHRONIC CONDITIONS C
  • [14] Centers for Medicare and Medicaid Services, 2021, PREL MED COVID 19 DA
  • [15] Racial and ethnic differences in COVID-19 hospitalizations by metropolitan status among Medicare beneficiaries, 1 January-31 December 2020
    Chang, Man-Huei
    Moonesinghe, Ramal
    Truman, Benedict, I
    [J]. JOURNAL OF PUBLIC HEALTH, 2022, 44 (02) : E211 - E220
  • [16] Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019-United States, February 12-March 28, 2020
    Chow, Nancy
    Fleming-Dutra, Katherine
    Gierke, Ryan
    Hall, Aron
    Hughes, Michelle
    Pilishvili, Tamara
    Ritchey, Matthew
    Roguski, Katherine
    Skoff, Tami
    Ussery, Emily
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (13): : 382 - 386
  • [17] Age-Related Differences in Hospitalization Rates, Clinical Presentation, and Outcomes Among Older Adults Hospitalized With Influenza-US Influenza Hospitalization Surveillance Network (FluSurv-NET)
    Czaja, Christopher A.
    Miller, Lisa
    Alden, Nisha
    Wald, Heidi L.
    Cummings, Charisse Nitura
    Rolfes, Melissa A.
    Anderson, Evan J.
    Bennett, Nancy M.
    Billing, Laurie M.
    Chai, Shua J.
    Eckel, Seth
    Mansmann, Robert
    McMahon, Melissa
    Monroe, Maya L.
    Muse, Alison
    Risk, Ilene
    Schaffner, William
    Thomas, Ann R.
    Yousey-Hindes, Kimberly
    Garg, Shikha
    Herlihy, Rachel K.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (07):
  • [18] Dooling K., 2020, PHAS ALL COVID 19 VA
  • [19] Dooling K, 2020, WORK GROUP CONS ACIP
  • [20] The impact of payor/provider type on health care use and expenditures among the frail elderly
    Experton, B
    Li, ZL
    Branch, LG
    Ozminkowski, RJ
    MellonLacey, DM
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1997, 87 (02) : 210 - 216